Supporting POYC medicines verification

With the new Falsified Medicines Directive coming into force on February 9, pharmaceutical companies are now also able to verify and decommission POYC medicines using Shireburn’s own EMVS module at the point-of-sale.

In addition to supporting pharmaceutical clients, ensuring their compliance with the EU Falsified Medicines Directive, Shireburn has extended support to also handle POYC dispensing.

The inclusion of the POYC functionality will ensure even smoother processing at the pharmacy and the use of one single software for all FMD compliance processing.

Pharmacies will not be required to enter POYC products into their inventory system in order to verify them as the new directive requires.

In addition, the new feature also supports the common practice whereby pharmacies pre-pack the POYC packages for patients.

Shireburn’s EMVS module was launched in December to help pharmaceutical businesses and pharmacies to automate adherence to the new directive. The European Medical Verification System (EMVS) is an initiative to protect the European pharmaceutical supply chain from the entry of falsified medicines and enforces verification of authenticity at the point of supply of all...